Skye Bioscience, Inc. Stock Issued During Period, Shares, New Issues
Skye Bioscience, Inc. (SKYE) reported Stock Issued During Period, Shares, New Issues of 24.00 thousand shares for the 1-month period ending 2015-03-31, per its 10-K filed 2017-03-10.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2017-03-10
- 2015-03-31: Stock Issued During Period, Shares, New Issues 1 month 24.00K shares.
- 2015-01-31: Stock Issued During Period, Shares, New Issues 1 month 241.66K shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|
| 2015-03-31 | 24.00K shares 10-K · filed 2017-03-10 |
| 2015-01-31 | 241.66K shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |